Outcome of Board Meeting held on 29.10.2026

Date: 29.10.2026 BSE Limited P.J. Towers, Dalal Street Mumbai - 400001 Sub: Outcome of Board Meeting held on 29.10.2026 under Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: Company’s Letter dated 23.10.2026 Unit: Bandaram Pharma Packtech Limited (Scrip Code: 524602) Dear Sir/Madam, With reference to the above-mentioned subject, this is to inform the Exchange that the meeting of Board of Directors of Bandaram Pharma Packtech Limited was held on Thursday, the 29th day of October, 2026 at 04.00 p.m. at the Registered Office of the Company at 601,5th Floor, Oxford Towers, opp to Leela Palace Hotel, Old Airport Road, Kodihalli, Bangalore, Bangalore, Karnataka, India, 560008. The Board has inter-alia considered and approved the following items: 1. Audited financial Results (Standalone and Consolidated) along with the Audit Reports (Standalone and Consolidated) for the quarter and half-year ended 30.09.2026. (Enclosed) The meeting concluded at 07:00 p.m. We request you to kindly take note of the same in your records. Thanking you. Yours sincerely, For Bandaram Pharma Packtech Limited Deepak Reddy Bandaram Chairman and Managing Director (DIN: 07074102) Encl: a/a CIN:L93090KA1993PLC159827 www.bandaram.com, Reg office. BANDARAM PHARMA PACKTECH LIMITED (Formerly Known as Shiva Medicare Limited) CIN: L93090KA1993PLC159827 Regd Office: 601,5th Floor, Oxford Towers, Opp. to Leela Palace Hotel, Old Airport Road, Kodihalli, Bangalore - 560008. Statement of Audited Results for the Quarter Ended and Six Months Ended 30.09.2026 (Amount Rs. in lakhs) STAND ALONE CONSOLIDATED Previous Previous Year For the Quarter ended Six Months ended For the Quarter ended Six Months ended Year ended ended S.No. Particulars 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (Audited) (Unaudited) (Unaudited) (Audited) (Unudited) (Audited) (Audited) (Unaudited) (Unaudited) (Audited) (Unudited) (Audited) I. Revenue from Operations 236.61 298.51 32.93 535.12 108.67 1,095.99 2,145.02 2,395.26 1,372.48 4 ,540.28 2,182.85 6 ,292.32 II. Other Income - - 0.83 - 0.83 0.83 - 0.03 0.83 0.03 0.83 1.80 III. Total income (I+II) 236.61 298.51 33.76 535.12 109.50 1,096.82 2,145.02 2,395.29 1,373.31 4,540.31 2,183.68 6 ,294.12 IV. Expenses (a) Cost of Materials 213.05 276.41 32.92 489.46 108.31 1,060.43 1,859.98 2,161.36 1,088.57 4,021.34 1,736.94 5 ,502.14 consumed (b) Purchase of stock-in- - - - - - - - - - - - - trade (c) Changes in inventories of finished goods, - - - - - - 12.45 ( 85.25) 142.73 - 72.80 136.56 (116.86) work-in-progress and stock- in-trade (d) Employee benefits 28.74 28.17 10.97 56.91 21.71 87.75 71.34 73.16 52.91 144.50 107.51 390.65 expenses (e) Finance Cost 0.02 - 0.03 0.02 0.03 0 .03 47.92 41.66 25.20 89.58 71.22 1 50.57 (f) Depreciation and - - 0.06 - 0.11 0 .21 25.44 20.37 13.62 45.81 27.06 9 7.37 amortisation expenses (h)Other expenses 35.84 29.61 24.52 65.45 40.93 64.42 85.40 91.50 42.51 176.90 93.07 226.12 Total Expenses 2 77.65 3 34.19 68.50 6 11.84 171.09 1 ,212.84 2,102.53 2 ,302.80 1,365.54 4,405.33 2,172.36 6 ,249.99 Profit / (Loss) before and V.exceptional items and Tax (41.04) (35.68) (34.74) (76.72) (61.59) (116.02) 42.49 92.49 7.77 134.98 11.32 44.13 ( III-IV) VI. Exeptional Items - - - - - - - - - - - - Profit / (Loss) from VII (41.04) (35.68) ( 34.74) (76.72) (61.59) ( 116.02) 42.49 92.49 7.77 134.98 11.32 44.13 before tax (V-VI) VIII. Tax expense Current Tax - - - - - 36.72 2 4.05 1.94 6 0.77 - 1 1.47 Deferred Tax - - 0.04 0.04 ( 0.11) (12.84) - (0.20) - 12.84 - 4 .51 Net Profit / (Loss) for the IX. period from Continuing (41.04) (35.68) ( 34.78) (76.72) (61.63) ( 115.91) 18.61 68.44 6.03 8 7.05 11.32 28.15 operations (VII-VIII) Profit/ (Loss) from discontinuing operations Tax Expense of XI - - - - - - - - - - - - discontinuing operations Profit/ (Loss) from XII discontinuing operations - - - - - - - - - - - - after tax Profit/(loss) for the Period XIII (41.04) (35.68) (34.78) (76.72) (61.63) (115.91) 18.61 68.44 6.03 87.05 11.32 28.15 (IX+XII) Other Comprehensive Incomes (i) Items that will not be A). - - - - - - - - - - - - recycled to profit or loss (a) Others (gratuity and leave encashment excess - - - - - - - - - - - - provision reversal) (ii) Income tax relating to items that will not be - - - - - - - - - - - - reclassified to profit or loss (i) Items that may be B). - - - - - - - - - - - - reclassified to profit or loss (ii) Income tax on items that may be reclassified to profit - - - - - - - - - - - - or loss Total Comprehensive - - - - - - - - - - - - Income Total Comprehensive XV Income for the period (41.04) (35.68) (34.78) (76.72) (61.63) (115.91) 18.61 68.44 6.03 87.05 11.32 28.15 (XIII+XIV) Attributable to Share holders of Bandaram - - - - - - (22.09) 18.91 3.32 (3.18) 6.23 (44.37) Pharma Packteck Limited Non Controlling Interest 40.69 49.53 2.71 90.22 5.09 72.52 Earnings Per Equity Share of face value of Rs.10/- XVI each)(for Countinuing opertions): 1) Basic (0.23) (0.20) (0.29) (0.43) (0.51) (0.64) (0.12) 0.11 0.03 (0.02) 0.05 (0.25) 2) Diluted (0.23) (0.20) (0.29) (0.43) (0.51) (0.64) (0.12) 0.11 0.03 (0.02) 0.05 (0.25) Earnings Per Equity Share of face value of Rs.10/- XVII each) (for Discountinuing opertions): 1) Basic (0.23) (0.20) (0.29) (0.43) (0.51) (0.64) (0.12) 0.11 0.03 (0.02) 0.05 (0.25) 2) Diluted (0.23) (0.20) (0.29) (0.43) (0.51) (0.64) (0.12) 0.11 0.03 (0.02) 0.05 (0.25) Earnings Per Equity Share of face value of Rs.10/- each) (for Continued and XVIII Discountinuing opertions): 1) Basic (0.23) (0.20) (0.29) (0.43) (0.51) (0.64) (0.12) 0.11 0.03 (0.02) 0.05 (0.25) 2) Diluted (0.23) (0.20) (0.29) (0.43) (0.51) (0.64) (0.12) 0.11 0.03 (0.02) 0.05 (0.25) Paid-up equity share capital XIX (Face Value of Rs. 10/- per 1,797.19 1,797.19 1,200.00 1,797.19 1 ,200.00 1,797.19 1,797.19 1,797.19 1 ,200.00 1 ,797.19 1 ,200.00 1,797.19 share) Notes: 1.. In pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 and Schedule III of the Companies Act, 2013, the above Financial Results have been prepared. The same is reviewed by the Statutory Auditors of Company and recommended by the Audit Committee and subsequently approved by the Board of Directors of Company at their meeting held on 29-10-2026. The Statutory auditors have expressed an unmodified audit opinion on these results. 2. The Financial Statements have been prepared in accordance with the recognition and measurement principles laid down in the Ind AS-34 "Interm Financial Reporting", prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued there under and other accounting propouncements generally accepted in India. 3. The figures of the previous year/periods have been re-grouped/re-classifed, wherever necessary, for the purpose of comparison with the current year/period figures. 4. Segmentwise reprot as per Ind AS -108 , is not applicable. 5.The above Financial Results are also available on the company's webiste www:bandaram.com 6. The Consolidated Results includes M/s VSR Paper and Packaging Limited & Craftsmart Products Private Limited (51.08% share in M/s VSR Paper and Packaging Limited and 100% in M/s Craftsmart Products Private Limited by M/s Bandaram Pharma Packteck Limited) ) For and on Behalf of the Board of Directors Bandaram Pharma Packtech Limited Deepak Reddy Bandaram Place : Bangalore Chairman & Managing Director Date : 29-10-2026 DIN: 07074102 Bandaram Pharma Packtech Limited (Formerly Known as Shiva Medicare Limited) CIN: L93090KA1993PLC159827 Regd Office: 601,5th Floor, Oxford Towers, opp to Leela Palace Hotel, Old Airport Road, Kodihalli Bangalore - 560008 Statement of Standalone Financial Position as at September 30, 2026 (Amt. Rs. In Lakhs) As at September 30, As at March 31, Particulars 2026 2026 I ASSETS 1 Non-current assets (a) Property, plant and equipment 0 .12 0 .12 (b) Right [Showing first 8,000 characters — download PDF for full document]